- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 13, 2026 | 20.19M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 20.19M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 18.15M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 15M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 15M sh |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$1.1M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$280.71K |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $295.83K |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $871.01K |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $480 |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $2.31M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $2.83M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $2.28M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $4.97M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $2.4M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $2.38M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $2.49M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $2.82M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $454.03K |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $239.03K |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $454.03K |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $9.97M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $2.61M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $4.07M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $2.76M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $14.94M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.03 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.23 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | −$0.03 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.03 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.23 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | −$0.03 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $635.25K |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $2.39M |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $134.82K |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $942.57K |
| Net Income | Q3 2026 · Jan 31, 2026 | −$548.34K |
| Net Income | Q3 2026 · Jan 31, 2026 | −$4.16M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$896.29K |
| Net Income | Q3 2026 · Jul 31, 2025 | −$2.72M |
| Net Income | Q3 2026 · Jan 31, 2025 | $23.42K |
| Net Income | Q3 2026 · Jan 31, 2025 | −$419.48K |
| Net Income | Q3 2026 · Oct 31, 2024 | −$114.37K |
| Net Income | Q3 2026 · Jul 31, 2024 | −$328.53K |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$551.61K |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$3.53M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $84.08K |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | −$696.69K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $83.66K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $168.6K |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | $244.63K |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | $332.22K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $1.3M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $1.3M |
| Cost Of Revenue restated | Q3 2026 · Jan 31, 2025 | $379.08K |
| Cost Of Revenue restated | Q3 2026 · Jan 31, 2025 | $428.36K |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.38M |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.47M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $623.71K |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $760.58K |